Targeted delivery via albumin corona nanocomplex to renal tubules to alleviate acute kidney injury

Renal tubular epithelial cell (RTEC) is a critical target cell for the treatment of acute kidney injury (AKI). Despite various RTEC targeting strategies using ligand modified nanoparticles (NPs) following systemic administration, the nonspecific interaction between NPs and plasma proteins greatly weakens the targeting efficiency as well as the stability of NPs. Herein, celastrol (CLT) was entrapped in D-alpha-tocopherol polyethylene glycol 1000 succinate (TPGS) forming a CLT-loaded nanocomplex core (CT) with a high loading capacity of similar to 50%. Bovine serum albumin (BSA) was then adsorbed onto the CT surface to afford a complete albumin corona without obvious denaturation (CTB). CTB showed uniform particle size distribution and sufficient stability in vitro and in vivo. Besides clathrin-mediated and macmpinocytosis pathways, CTB was actively internalized through megalin receptor-mediated endocytosis in HK-2 cells. Per biodistribution studies, CTB demonstrates enhanced renal tubule-specific distribution and targetability in mice compared to CT without albumin corona. Furthermore, pharmacodynamic studies in vivo further support that CTB effectively alleviated ischemia-reperfusion induced injuries without obvious systemic side effects in AKI mice models.

Automated summary

In this study, a high loading capacity nanocomplex core was developed with celastrol entrapped in D-alpha-tocopherol polyethylene glycol 1000 succinate. Bovine serum albumin was adsorbed onto the core surface to improve the targeting efficiency and stability. The nanocomplex showed good stability and renal tubule-specific distribution in in vitro and in vivo experiments. Pharmacodynamic studies demonstrated that the nanocomplex effectively alleviated acute kidney injury-induced injuries.